[Biomarkers in cardiology--state of the art 2007].
Biomarkers have gained increasing significance in clinical cardiology during the last two decades. Laboratory parameters play an important role as risk markers for coronary events in primary and secondary prevention, in the diagnosis of acute myocardial necrosis and heart failure as well as in the management of patients with heart valve diseases. The development of novel biochemical markers has also led to new insights in the pathophysiology of coronary artery disease, acute coronary syndromes and heart failure. This review summarizes the state of the art of cardiac biomarkers suitable for routine use.
Mair
Johannes
J
Klinische Abteilung für Kardiologie, Universitätsklinik für Innere Medizin, Medizinische Universität Innsbruck, Innsbruck, Austria. Johannes.Mair@i-med.ac.at
D015415:Biomarkers / Q000097:blood*; D002097:C-Reactive Protein / Q000378:metabolism; D003327:Coronary Disease / Q000097:blood / Q000175:diagnosis; D006331:Heart Diseases / Q000097:blood / Q000175:diagnosis*; D006333:Heart Failure / Q000097:blood / Q000175:diagnosis; D006349:Heart Valve Diseases / Q000097:blood / Q000175:diagnosis; D006710:Homocysteine / Q000097:blood; D006801:Humans; D017270:Lipoprotein(a) / Q000097:blood; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis; D020097:Natriuretic Peptide, Brain / Q000097:blood; D010446:Peptide Fragments / Q000097:blood; D011237:Predictive Value of Tests; D011379:Prognosis; D018570:Risk Assessment; D014336:Troponin / Q000097:blood
D015415:Biomarkers; D017270:Lipoprotein(a); D010446:Peptide Fragments; D014336:Troponin; C109794:pro-brain natriuretic peptide (1-76); D006710:Homocysteine; D020097:Natriuretic Peptide, Brain; D002097:C-Reactive Protein